MELBOURNE, Fla., April 11, 2018 -- Since 2003, National Association of Professional Background Screeners (NAPBS) has represented the interest of companies offering employment and tenant background screening services. This spring, NAPBS will hold it’s 2018 Mid-Year Legislative & Regulatory Conference. This conference focuses on regulation, legislation, education, and compliance related to the background screening industry. National Drug Screening’s Tom Fulmer will facilitate a break out session during the April 15-17 event in Washington, DC.
|
|||||
The session, titled “Surviving the Shifts: The Changing Face of Engagement” will focus on the dynamic and quickly changing business aspects of the drug and background screening service industry. Mr. Fulmer cited that he is “excited to have been invited to present this break out session among leaders in the industry.” Mr. Fulmer’s presentation will provide value for all those who attend. He continues, “There’s something for everyone in this breakout session. Whether you are new to the drug testing and screening world or an industry veteran, there will be valuable takeaways.”
In his position as Vice President of Business Development at National Drug Screening, Mr. Fulmer helps companies reduce and manage risk and exposure within their work environments by providing drug testing solutions, MRO services, supervisor, collector & DER training, and program support & management services for employers and other drug testing companies.
Registration for the NAPBS 2018 Mid -Year Legislative & Regulatory Conference is currently open. More information can be found at the NAPBS website.
About National Drug Screening, Inc: Located on the east coast of Central Florida, National Drug Screening, Inc. offers nationwide service for drug test result reporting by state of the art MRO services, drug testing software, immediate drug tests, drug & alcohol testing for employees. NDS specializes in Drug Screening, Immediate Testing, Drug-Free Workplace programs, DOT Compliance, Employer Programs, and customized Employer Drug Screening Programs.
A photo accompanying this announcement is available at http://resource.globenewswire.com/Resource/Download/08920b7d-0a0f-4e21-b2ca-176de5211f36
Joe Reilly
National Drug Screening, Inc
866-843-4545
[email protected]
www.nationaldrugscreening.com


Tesla Weighs China Business Separation Amid SpaceX Merger Speculation
Apple Stock Slides 7% as Weak Sales Forecast Overshadows Quarterly Earnings Beat
Prysmian Nears Deal to Acquire Atkore in Potential All-Cash Takeover
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Robinhood Q2 Earnings Beat Estimates, But HOOD Stock Falls as Investors Question Profit Quality
Capital One Says AML Review Led to Closure of Trump Organization Accounts
Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says
Anthropic Reveals Claude AI Accessed Real Production Systems During Cybersecurity Tests
Toyota First-Half Global Sales and Production Decline on Weak China Demand, RAV4 Transition
WestJet Cancels 86 Flights as CUPE Strike Threat Disrupts Travel
Amazon Q2 Earnings Beat Estimates as AWS AI Growth Surges, But Q3 Revenue Forecast Disappoints
FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners
Chery Invests $75 Million in KG Mobility to Expand Global Automotive Partnership
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat
World game at war: why some European nations have threatened a World Cup boycott
Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight
Same sparkle, different story: how lab-grown diamonds are transforming the market 



